1600 W Merit Pkwy
South Jordan, Utah 84095-2416
Phone: 18012531600
www.merit.com
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology,
Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients SOUTH JORDAN, Utah, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of its Aspira Bottle. The new evacuated drainage
Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients
Merit Medical Systems has been impacted by recent acquisitions and Q2 numbers. Click here to find out why MMSI stock is a Hold.
On August 3, 2023, Merit Medical Systems, Inc. proudly announced the successful completion of enrollment in its groundbreaking WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. This remarkable study, known as WAVE, is a one-of-a-kind, prospective, randomized, controlled, multicenter study that aims to compare the revolutionary Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) with the traditional balloon angioplasty […] The post Merit Medical Systems Inc Completes Enrollment in Groundbreaking WAVE Study for Arteriovenous Access Treatment appeared first on Best Stocks .
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced
https://www.investing.com/news/assorted/merit-medicals-wrapsody-arteriovenous-access-efficacy-wave-pivotal-study-completes-enrollment-432SI-3143991
SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable
SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) to percutaneous transluminal angioplasty for treatment of stenosis/occlusion in the venous outflow circuit in patients undergoing hemodialysis.
In a dramatic move that has sent waves through the financial sector, Amalgamated Bank has significantly reduced its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI). This surprising development was revealed in the bank’s Form 13F filing with the Securities and Exchange Commission (SEC) for the first quarter of this year, marking yet another noteworthy event […] The post Amalgamated Bank Makes Startling Reduction in Stake in Merit Medical Systems appeared first on Best Stocks .